Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme lactation study in women with MPS I and their breastfed infants
2007-007003-33Phase 4Active
- Sponsor
- Sanofi
- Start
- Dec 2010
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Primary endpoints: Effect of Aldurazyme on lactation in mothers, Presence of alpha-L-iduronidase in breast milk and 1 more. Started Dec 2010; status: active.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on 2007-007003-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007003-33.